I’m a bowel cancer surgeon. 5-FU is the cornerstone systemic treatment for bowel cancer, so anything that improves sensitivity could be a big deal. There are so many research avenues to pursue, and it’s ubiquity in various cancer types indicates that we are really only the tip of the iceberg as to its potential. Once FTO gains some scientific traction, I would expect a flurry of medical and investment interest.
I’m happy to have been buying again at these levels, and I’m predicting that 1.50 is well and truly within the company buying range as a support.
I’m a bowel cancer surgeon. 5-FU is the cornerstone systemic...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
-0.010(0.81%) |
Mkt cap ! $202.7M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.14 | $381.6K | 320.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7000 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.22 | 2171 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.17 |
Change
-0.010 ( 5.54 %) |
||||
| Open | High | Low | Volume | ||
| $1.23 | $1.23 | $1.14 | 48407 | ||
| Last updated 15.52pm 03/05/2024 ? | |||||
| RAC (ASX) Chart |